Millipore Corp. Earnings Conference Call (Q2 2009)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Aug 6 Calls Today's Calls

Call Details Millipore Corp. Earnings Conference Call (Q2 2009) Thu, Aug 6, 2009, 4:45 pm Eastern Listen to the archived event audio About Millipore Corp. (NYSE:MIL) Millipore Corporation, a life science company, provides technologies, tools, and services for bioscience research and biopharmaceutical manufacturing industry in the Americas, Europe, and the Asia Pacific. It operates in two segments, Bioprocess and Bioscience. The Bioprocess segment develops, manufactures, and sells consumable products and hardware, as well as provides related services used principally in the development and manufacture of therapeutic products. This segment serves biotechnology companies, pharmaceutical companies, contract drug manufacturers, and beverage companies. The Bioscience segment manufactures and sells instrumentation, consumable products, and services used in drug discovery and other laboratory applications. This segment serves research laboratories at academic institutions, research departments at biotechnology and pharmaceutical companies, life science research companies, privately funded research laboratories, hospitals and clinical laboratories, clinical research organizations, and environmental, industrial, and other analytical laboratories. The company sells its products through its direct sales force, Web site, and independent distributors. Millipore Corporation has partnership agreements with Guava Technologies, Inc.; Luminex; Gen-Probe; Novozymes; Novo Nordisk; Rohm and Haas; and Microbix Biosystems Inc. The company was founded in 1954 and is headquartered in Billerica, Massachusetts. More Info: Quote | Chart | News | Profile | Reports | Research | SEC | Msgs | Insider | Financials | Analyst Ratings